Now Playing

Januvia and Byetta may increase chances of developing pancreatic cancer

posted on:
November 4, 2014

Januvia, Byetta

In this episode of the Beasley Allen Report, host Gibson Vance welcomes fellow Beasley Allen attorney David Dearing to discuss the dangers of type 2 diabetes drugs, such as Januvia and Byetta. Dearing, originally from Jacksonville, Fla., originally went to law school in order to pursue law enforcement. After spending five years as a state prosecutor, Dearing decided to stay in the legal field. He eventually moved from Jacksonville to Montgomery with his wife and was hired by Beasley Allen in 2012.

According to Dearing, diabetes is caused by a condition called hyperglycemia, which occurs when the individual cannot absorb all of the sugar the body brings in. The condition leads to a number of adverse health effects, as well as type 2 diabetes, which is why diabetics must monitor their blood sugar so closely. A number of diabetes drugs, known as incretin mimetics have been prescribed to diabetics to help control their blood sugar levels; however, an alarming amount of patients taking these incretin mimetics have reported pancreatic cancer. According to new research published in the British Medical Journal, drugs like Januvia and Byetta put diabetics at a higher risk of developing pancreatic cancer, pancreatitis and thyroid cancer due to pancreatic inflammation.

Courtesy of: Beasley Allen Report

back to top